Cholangiocarcinoma, Intrahepatic

specific

A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree. Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor.

Centers

Active Trials

—

Cancer Funding

Top Centers for Cholangiocarcinoma, Intrahepatic(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	—	—	53.8
2	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive	—	—	53.8
3	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	53.8
4	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	—	53.8
5	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	53.8
6	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	53.8
7	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive	—	—	53.8
8	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	53.8
9	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	53.8
10	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	53.8
11	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive	—	—	53.8
12	Boston University Cancer CenterBoston, MA	—	—	53.8
13	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	—	—	53.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →